Hepatitis B immunisation in children aged 10-13 years in New South Wales, 2001.

Vol. 14 No. 1–2 17 6. Hull BP, McIntyre PB, Heath TC, Sayer GP. Measuring immunisation coverage in Australia. A review of the Australian Childhood Immunisation Register. Aust Fam Physician 1999;28:55–60. 7. Gilbert GL, Escott RG, Gidding HF, et al. Impact of the Australian Measles Control Campaign on immunity to measles and rubella. Epidemiol Infect 2001;127:297–303. 8. Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect 1995;115:139–56. 9. Gay NJ, Pelletier L, Duclos P. Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy. Vaccine 1998;16:794–801. 10. Diekmann O, Heesterbeek JA, Metz JA. On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol 1990;28:365–82. 11. Pareek M, Pattison HM. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate. Br J Gen Pract 2000;50:969–71. 12. Petrovic M, Roberts R, Ramsay M. Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. Br Med J 2001;322:82–5. 13. Hull BP, Lawrence G, MacIntyre CR, McIntyre PB. Immunisation Coverage: Australia 2001. Canberra: Commonwealth Department of Health and Ageing; 2002.